A new AI capability that delivers analysis-ready Media Intelligence. More than just a product launch, this is a shift in how communications teams monitor, understand and act on media coverage.
Abstract Ageing is accompanied by declining memory function, with extremely heterogeneous manifestation in the human population1. Brain-extrinsic factors influencing cognitive decline, such as gastrointestinal signals, have emerged as attractive targets for peripheral interventions2,3,4,5,6, but the underlying mechanisms remain largely unclear.
1 Introduction Lipid nanoparticles (LNPs) are a versatile delivery system with immense therapeutic potential due to their ability to encapsulate nucleic acid therapies [1]. In the past, LNPs have traditionally been loaded with messenger RNA (mRNA), as in the COVID-19 vaccines, to express encoded proteins as therapies or antigens [2].
Research identifies MEF2C as a human-specific switch that keeps microglia in balance. Loss of MEF2C tips microglia toward inflammatory and aging-like states that link to autism and Alzheimer’s disease.